These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1284884)

  • 1. [Post-transfusion non-A, non-B hepatitis: towards risk zero].
    de Andrade Júnior DR; de Andrade DR
    Arq Gastroenterol; 1992; 29(1):1-4. PubMed ID: 1284884
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of post-transfusion hepatitis non-A, non-B. Report established by the National Agency for the Development of Medical Evaluation on demand of the General Health Direction].
    Gayno S
    Gastroenterol Clin Biol; 1991; 15(8-9):667-8. PubMed ID: 1752387
    [No Abstract]   [Full Text] [Related]  

  • 3. [Incidence of anti-HCV and ALT in blood donors].
    Martín Y; Marzo L; Cinto F; Delgado P; Buñuel C
    Sangre (Barc); 1990 Jun; 35(3):197-200. PubMed ID: 2118686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-HCV antibodies among blood donors in Cantabria. Incidence and relation to transaminase levels].
    Pastor JM; Hermosa V; Ruiz Tagle MA; Zubizarreta A
    Sangre (Barc); 1990 Jun; 35(3):205-7. PubMed ID: 2118687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-A, non-B hepatitis surrogate testing of blood donations.
    Lancet; 1987 Jun; 1(8546):1366-7. PubMed ID: 2884466
    [No Abstract]   [Full Text] [Related]  

  • 6. [Public Health Council advisory: prevention of post-transfusion non-A non-B hepatitis; is application of a surrogate test a missed station?].
    Brandt KH
    Ned Tijdschr Geneeskd; 1989 Nov; 133(45):2212-4. PubMed ID: 2509949
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lessening the risk of transmission of hepatitis C virus by labile blood products: a role for indirect markers?].
    Jullien AM; Courouce AM; Maniez M; Brevière D; Menault M; Finetti P; Girard M
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):355-8. PubMed ID: 2177598
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Post-transfusional non-A non-B hepatitis. Evaluation of SGPT screening in blood donors].
    Muglia M; Angeloni U; Angeloni P
    Boll Ist Sieroter Milan; 1989; 68(1):28-33. PubMed ID: 2518810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor serum alanine aminotransferase activity and the risk of transfusion-associated hepatitis.
    Lenes BA; Tomasulo P; Alter HJ; Holland PV
    N Engl J Med; 1983 Mar; 308(12):723. PubMed ID: 6402702
    [No Abstract]   [Full Text] [Related]  

  • 11. The declining risk of post-transfusion hepatitis C virus infection.
    Donahue JG; Muñoz A; Ness PM; Brown DE; Yawn DH; McAllister HA; Reitz BA; Nelson KE
    N Engl J Med; 1992 Aug; 327(6):369-73. PubMed ID: 1320736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention for hepatitis C virus transmission].
    Sekiguchi S
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):473-6. PubMed ID: 7687974
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current status of anti-HCV screening and posttransfusion hepatitis].
    Kiyokawa H
    Rinsho Byori; 1992 Sep; 40(9):925-8. PubMed ID: 1279246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alanine aminotransferase and posttransfusion hepatitis.
    Lacher DA
    JAMA; 1987 Feb; 257(8):1048. PubMed ID: 3100827
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
    Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
    N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening of blood donors for the prevention of non-A, non-B hepatitis].
    Seidl S
    Dtsch Med Wochenschr; 1983 Jan; 108(4):123-4. PubMed ID: 6402351
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Japanese Red Cross Non-A, Non-B Hepatitis Research Group.
    Lancet; 1991 Oct; 338(8774):1040-1. PubMed ID: 1681356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
    Alter HJ; Purcell RH; Shih JW; Melpolder JC; Houghton M; Choo QL; Kuo G
    N Engl J Med; 1989 Nov; 321(22):1494-500. PubMed ID: 2509915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-transfusion hepatitis C virus infection.
    Kleinman S; Busch M; Holland P
    N Engl J Med; 1992 Nov; 327(22):1601-2. PubMed ID: 1279422
    [No Abstract]   [Full Text] [Related]  

  • 20. [Incidence of an antigen/antibody system characterizing 1 subgroup of posttransfusion non-A, non-B hepatitis].
    Renger FG; Raabe A; Forster H; Knot E
    Vutr Boles; 1986; 25(5):62-4. PubMed ID: 2433838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.